Market Movers Archives | Page 646 of 871 | Smartkarma

China Cinda Asset Management (1359)

1.31 HKD -0.01 (-0.76%) Volume: 416.98M

China Cinda Asset Management’s stock price currently stands at 1.31 HKD, experiencing a slight dip of -0.76% this trading session, despite a substantial YTD increase of +67.95%. The trading volume for 1359 is a robust 416.98M, reflecting the market’s active interest in this leading asset management firm.

Latest developments on China Cinda Asset Management

China Cinda Asset Management‘s stock price experienced significant fluctuations today following the release of their quarterly earnings report, which showed a decrease in profits compared to the previous quarter. Investors reacted to this news by selling off their shares, causing a sharp drop in the stock price. Additionally, concerns about the impact of the ongoing trade tensions between the US and China on the company’s business operations also contributed to the stock price movements. Despite these challenges, China Cinda Asset Management remains optimistic about its long-term growth prospects and is implementing strategies to mitigate the effects of economic uncertainties.

A look at China Cinda Asset Management Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Cinda Asset Management Company Ltd. is positioned well for the long-term with a strong focus on value and momentum, according to Smartkarma Smart Scores. With a top score in value and momentum, the company showcases its ability to provide asset management services effectively. However, its lower scores in growth and resilience might pose challenges in the future. Investors should keep an eye on how China Cinda Asset Management navigates these factors to sustain its success.

As per Smartkarma Smart Scores, China Cinda Asset Management Company Ltd. excels in providing value and dividend returns to its investors. With a solid score in dividends and a perfect score in value, the company demonstrates its commitment to delivering returns to shareholders. However, its lower scores in growth and resilience could indicate potential obstacles in the future. It will be crucial for China Cinda Asset Management to address these areas to ensure its long-term stability and growth.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Sunac China Holdings (1918)

2.45 HKD +0.04 (+1.66%) Volume: 625.35M

Experience the robust growth of Sunac China Holdings’s stock price, currently trading at 2.45 HKD, demonstrating an impressive trading session increase of 1.66%. With a substantial trading volume of 625.35M and a phenomenal YTD percentage change of 63.33%, Sunac China Holdings (1918) remains a compelling choice for investors in the Chinese real estate market.

Latest developments on Sunac China Holdings

Sunac China Holdings stock price experienced a surge today following the announcement of their strategic partnership with a major real estate developer. This partnership is expected to boost Sunac’s market position and drive future growth. Additionally, positive economic data released earlier in the week has also contributed to the bullish sentiment surrounding the company. Investors are optimistic about Sunac’s prospects in the real estate sector, leading to increased buying activity and driving up the stock price. The company’s strong performance and promising partnerships have positioned Sunac China Holdings as a key player in the market today.

A look at Sunac China Holdings Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Sunac China Holdings has a promising long-term outlook. With high scores in Growth and Momentum, the company is positioned well for future expansion and market performance. Its strong value score also indicates that it is currently undervalued, presenting a potential investment opportunity for those looking for value stocks in the real estate sector.

However, Sunac China Holdings‘ low scores in Dividend and Resilience suggest that it may not be the best choice for investors seeking steady income or a stable financial position. Despite this, the company’s overall outlook remains positive, especially for those interested in capitalizing on its growth potential in the real estate market.

### Sunac China Holdings Limited is a real estate development company. ###

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Shanghai Electric Group (2727)

2.37 HKD +0.55 (+30.22%) Volume: 424.55M

Shanghai Electric Group’s stock price soars to 2.37 HKD, marking an impressive trading session surge of +30.22% and a year-to-date increase of +45.40%, on a robust trading volume of 424.55M, highlighting the strong momentum and investor confidence in the company’s growth prospects.

Latest developments on Shanghai Electric Group

Shanghai Electric Group Company has been making strategic moves in the market recently, with plans for a share buy-back and a strategic acquisition. These announcements have sparked investor interest and anticipation, leading to fluctuations in the company’s stock price today. With a focus on expanding its market presence and strengthening its position in the industry, Shanghai Electric is positioning itself for future growth and success.

A look at Shanghai Electric Group Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Shanghai Electric Group Company Limited has received a high score for its value and growth potential according to Smartkarma Smart Scores. The company is well-positioned in the power equipment, electromechanical equipment, transportation equipment, and environmental system industries, indicating a positive long-term outlook for investors.

However, Shanghai Electric Group Company‘s dividend score is on the lower end, suggesting that it may not be the best option for investors seeking regular income. With moderate scores for resilience and momentum, the company shows stability and potential for future growth. Overall, Shanghai Electric Group Company Limited presents a strong value proposition with promising growth opportunities in various industries.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

GCL Technology Holdings (3800)

1.16 HKD +0.02 (+1.75%) Volume: 514.18M

GCL Technology Holdings’s stock price sees a promising surge of +1.75% this trading session, closing at 1.16 HKD with an impressive trading volume of 514.18M. Despite a year-to-date decrease of -6.45%, the recent uptick indicates potential for a positive market trend.

Latest developments on GCL Technology Holdings

Gcl Poly Energy Holdings Limited stock price saw a significant increase today following the announcement of their partnership with a leading solar energy company to develop a new line of high-efficiency solar panels. This collaboration comes after Gcl Poly Energy Holdings Limited reported strong quarterly earnings, beating market expectations. Investors are optimistic about the company’s future growth potential in the renewable energy sector, leading to a surge in stock price. Additionally, recent government incentives for clean energy projects have also boosted investor confidence in Gcl Poly Energy Holdings Limited, further driving up their stock price.

A look at GCL Technology Holdings Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Gcl Poly Energy Holdings Limited has a moderate overall outlook. The company scores average in value, dividend, resilience, and momentum, indicating stability in these areas. However, its growth score is slightly lower, suggesting potential challenges in expanding its operations in the future. Despite this, Gcl Poly Energy Holdings Limited remains a key player in the Chinese power industry, focusing on the production of solar grade polysilicon and operating cogeneration plants.

Gcl Poly Energy Holdings Limited‘s Smartkarma Smart Scores highlight its position as a reliable and steady company in the market. With average scores across key factors such as value, dividend, resilience, and momentum, the company demonstrates consistency and strength in its operations. While its growth score is not as high, Gcl Poly Energy Holdings Limited continues to play a significant role in the Chinese power sector, emphasizing its commitment to producing solar grade polysilicon and operating cogeneration plants.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Gen Digital Inc. (GEN)

27.20 USD -0.86 (-3.06%) Volume: 2.98M

Gen Digital Inc.’s stock price is currently at 27.20 USD, experiencing a slight dip this trading session by -3.06% with a trading volume of 2.98M. Despite this, GEN’s year-to-date performance remains strong with a positive change of +19.19%, showcasing its resilience in the stock market.

Latest developments on Gen Digital Inc.

and Forecast 2021-2026
Genesis Healthcare, a leading healthcare company, has recently kicked off their annual Tree of Love fundraiser, showcasing their commitment to giving back to the community. This event comes amidst a backdrop of positive news for the company, as the Long Term Care Therapy Management Market is projected to experience significant growth in the coming years. Investors are taking note of these developments, with Genesis Healthcare‘s stock price showing movement in response to these promising market forecasts. Stay tuned as the company continues to make strides in both philanthropy and market performance.

A look at Gen Digital Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Genesis Healthcare has a promising long-term outlook based on the Smartkarma Smart Scores. With high scores in Growth and Resilience, the company is positioned for strong expansion and the ability to withstand challenges. This indicates that Genesis Healthcare is likely to continue growing and adapting to changes in the healthcare industry, making it a favorable investment option for those looking for sustained growth.

Although Genesis Healthcare may not score as high in other areas such as Value and Momentum, its strong performance in Growth and Resilience suggests that the company has a solid foundation for long-term success. With a focus on providing a range of care options and services, including specialized care and rehabilitation, Genesis Healthcare is well-positioned to meet the evolving needs of its customers and maintain its position in the market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Vertex Pharmaceuticals Incorporated (VRTX)

483.00 USD -15.73 (-3.15%) Volume: 2.24M

Vertex Pharmaceuticals Incorporated’s stock price stands at 483.00 USD, experiencing a dip of 3.15% this trading session, with a trading volume of 2.24M. Despite the daily fluctuation, VRTX’s stock has shown a robust YTD increase of 18.71%, highlighting its strong market performance.

Latest developments on Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals (NASDAQ:VRTX) has been making waves in the market recently, with its stock price seeing fluctuations amidst a series of key events. The company’s RS rating has climbed to 74, indicating positive momentum. Analysts at UBS have raised the price target for Vertex to $562 from $477, highlighting optimism for the future. Despite a recent 3.5% drop in stock price, Vertex Pharmaceuticals Inc. continues to outperform competitors on strong trading days. Additionally, Vertex is set to present Phase 3 data on Suzetrigine at the American Society of Anesthesiologists Annual Meeting, showcasing its potential as a first-in-class pain signal inhibitor. With analysts at Scotiabank initiating coverage and UBS resuming coverage with a buy rating, Vertex Pharmaceuticals is poised for growth despite the choppy ride ahead.

A look at Vertex Pharmaceuticals Incorporated Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Vertex Pharmaceuticals has received a mixed outlook based on Smartkarma Smart Scores. While the company scored high in Momentum, indicating a positive trend in its stock performance, it scored lower in areas such as Value and Dividend. This suggests that investors may see potential for growth in the company’s stock price in the near future, but may not expect significant returns in the form of dividends. Overall, Vertex Pharmaceuticals seems to have a moderate long-term outlook, with its Resilience score indicating a certain level of stability in the face of market fluctuations.

Vertex Pharmaceuticals Incorporated is a company that focuses on discovering, developing, and commercializing pharmaceutical products for various medical conditions. With a particular emphasis on treatments for cystic fibrosis, cancer, and autoimmune diseases, Vertex Pharmaceuticals serves the healthcare sector globally. Despite some mixed scores in Smartkarma’s assessment, the company’s overall outlook appears to be steady, with room for growth and a demonstrated ability to weather market challenges.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Fair Isaac Corporation (FICO)

1973.46 USD -65.49 (-3.21%) Volume: 0.21M

Discover Fair Isaac Corporation’s stock price, exhibiting a robust performance with its current price at 1973.46 USD despite a slight dip of -3.21% this trading session. With a trading volume of 0.21M and an impressive YTD increase of +69.54%, FICO’s stock continues to showcase promising potential for investors.

Latest developments on Fair Isaac Corporation

Today, Fair Isaac Corporation (FICO) stock price is experiencing fluctuations following recent events. Jim Cramer has praised FICO as being the best at what it does, highlighting the company’s strong position in the market. However, lawmakers and MBA have raised concerns over potential price hikes by FICO, particularly in mortgage credit scores, with predictions of costs increasing by up to 50%. The valuation of Fair Isaac Corporation is now being scrutinized for its rapid growth. Investors are anticipating another round of price increases for FICO scores in 2025, adding to the uncertainty surrounding the company’s stock performance.

A look at Fair Isaac Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Fair Isaac Corp is positioned for strong long-term growth and resilience. With a Growth score of 4 and a Resilience score of 5, the company is expected to continue expanding and adapting well to market challenges. This indicates that Fair Isaac Corp has a solid foundation for future success and sustainability.

Additionally, the Momentum score of 5 suggests that Fair Isaac Corp is currently experiencing positive market momentum, which could further bolster its long-term outlook. While the company may not offer high dividends or be considered undervalued based on the Value score of 0, its overall performance in growth, resilience, and momentum positions it well for continued success in the future.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

American Express Company (AXP)

276.79 USD -8.99 (-3.15%) Volume: 7.87M

American Express Company’s stock price stands at 276.79 USD, witnessing a drop of 3.15% this trading session, with a trading volume of 7.87M. Despite the recent dip, the stock showcases a strong YTD performance, gaining 47.75%, signalling a robust financial year for AXP.

Latest developments on American Express Company

American Express Co is showing bullish signals ahead of its Q3 earnings, with profit beating estimates and card spending growing. The company has revised its annual outlook, reporting a 6% growth in spending that has led to its stock heading higher. Despite mixed Q3 results, analysts see a silver lining in expense management and net interest income growth. American Express CEO remains optimistic about the company’s future, emphasizing continued customer spending. However, the stock is currently in the red today, possibly due to missing revenue estimates. With strong trading performance and positive earnings, American Express continues to be a key player in the financial market.

A look at American Express Company Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, American Express Co has a positive long-term outlook. With high scores in Growth, Resilience, and Momentum, the company is positioned well for future success. The company’s strong momentum indicates that it is performing well in the market, while its resilience score suggests that it can weather economic downturns. Additionally, the high growth score indicates that American Express Co has potential for expansion and increased profitability in the future.

American Express Company is a global payment and travel company that offers charge and credit payment card products as well as travel-related services to consumers and businesses worldwide. While the company received moderate scores in Value and Dividend, its strong performance in Growth, Resilience, and Momentum bodes well for its long-term outlook. Overall, American Express Co appears to be in a solid position for continued success and growth in the future.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Elevance Health, Inc. (ELV)

430.77 USD -13.58 (-3.06%) Volume: 3.32M

Elevance Health, Inc.’s stock price is currently standing at 430.77 USD, experiencing a dip of 3.06% this trading session with a trading volume of 3.32M. The stock has seen a downward trend YTD, with a percentage change of -8.65%, indicating a challenging market environment for ELV.

Latest developments on Elevance Health, Inc.

Elevance Health, Inc. (ELV) faced a turbulent period as it reported lower-than-expected earnings, attributing the profit decline to persistently high medical costs and ‘unprecedented’ challenges in the Medicaid sector. The company’s Q3 earnings call highlighted the impact of Medicaid redeterminations on its financial performance, leading to a soft annual outlook and a subsequent drop in stock price. Despite revenue growth and beating expectations, Elevance Health’s profit fell short, causing analysts to cut their forecasts and prompting a 12% plunge in stock value. The company’s struggles with rising medical expenses post-COVID-19 policies have led to a cautious market sentiment, reflected in a 2.5% trading dip and a lowered price target by financial institutions. Despite maintaining its dividend payout, Elevance Health’s stock price remains under pressure due to ongoing Medicaid challenges and lower earnings projections.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Archer-Daniels-Midland Company (ADM)

56.40 USD -2.23 (-3.80%) Volume: 4.33M

Archer-Daniels-Midland Company’s stock price is currently standing at 56.40 USD, experiencing a downturn this trading session by -3.80% with a trading volume of 4.33M, reflecting a year-to-date percentage change of -21.91%, indicating a challenging market performance for ADM.

Latest developments on Archer-Daniels-Midland Company

Archer Daniels Midland Co. has been facing a tumultuous period recently, with a lawsuit alleging misconduct and lack of safety inspections after an explosion injured a US worker. Despite this, the company’s stock managed to outperform competitors on a strong trading day, only to see a 3.5% decrease in stock price shortly after. Notable option activity involving ADM was observed on Friday, while Marathon Asset Management Ltd purchased a significant number of shares in the company. However, ADM’s stock underperformed on Wednesday despite daily gains, and a decline in short interest was noted. These events have contributed to the fluctuations in Archer Daniels Midland Co.’s stock price movements today.

Archer-Daniels-Midland Company on Smartkarma

Analysts on Smartkarma have provided mixed coverage of Archer Daniels Midland Co. Baptista Research has a bullish outlook, highlighting the company’s robust cash flow and operational improvements in the second quarter of 2024. On the other hand, Srinidhi Raghavendra’s bearish analysis points out weak results in Ag Services & Oilseeds and Nutrition businesses, leading to underperformance against analyst expectations. Despite this, Baptista Research remains optimistic about ADM’s strengthening margins through operational improvements and renewable production, emphasizing the company’s proactive risk management strategies.

Value Investors Club’s report on Archer Daniels Midland Co raises concerns about a 22% stock drop due to an investigation into the Nutrition segment’s accounting practices. While this presents a potential buying opportunity, there are fears of inflated profitability and a possible scandal. However, the underlying business is expected to weather the storm, with the issue unlikely to have pervasive effects similar to past corporate scandals like Enron. Investors are advised to consider these varied perspectives on ADM’s financial prospects before making investment decisions.

A look at Archer-Daniels-Midland Company Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Archer Daniels Midland Co, a company that deals with agricultural commodities and products, has received overall positive scores in various factors according to Smartkarma Smart Scores. With a strong Dividend score of 5, investors can expect consistent returns from the company. Additionally, the company scores well in Value and Growth, indicating a promising long-term outlook for potential growth and value appreciation. However, its Resilience score of 3 suggests some vulnerability to market fluctuations, despite a solid Momentum score of 4.

Archer Daniels Midland Co‘s focus on processing oilseeds, corn, oats, and other agricultural products for food and feed ingredients positions it well for future growth and stability. With favorable scores in Dividend and Growth, the company shows potential for sustained performance and shareholder returns. While its Resilience score may indicate some risk, the overall positive outlook from Smartkarma Smart Scores suggests that Archer Daniels Midland Co is well-positioned for long-term success in the agricultural commodities market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma